Akshara Srivastava, Sharleen D'Souza, &Amp; Sohini Das

Stories by Akshara Srivastava, Sharleen D'Souza, &Amp; Sohini Das

Discounts are back at car dealerships

Discounts are back at car dealerships

Rediff.com   21 Mar 2025

Dealers said the discounts this March are higher than the same month in the previous year.

PV Sales Face Bleak Outlook in 2024-25

PV Sales Face Bleak Outlook in 2024-25

Rediff.com   20 Mar 2025

Major Indian carmakers are preparing for sluggish domestic PV sales growth of just 1-2 per cent in FY26.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com   20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

For Tesla, India is a challenge as well as opportunity

For Tesla, India is a challenge as well as opportunity

Rediff.com   19 Mar 2025

With India's EV penetration at just 2.5 per cent, the market presents an opportunity -- provided Tesla gets its pricing right.

AC prices likely to go up by 4-5% due to component shortages

AC prices likely to go up by 4-5% due to component shortages

Rediff.com   18 Mar 2025

As temperatures shoot up this month signalling an early onset of summer, sales of air conditioners (AC) are set to increase, with companies expected to hike the prices of ACs by 4-5 per cent due to component shortages. Leading players like Haier and Bluestar and suppliers like EPack Durables have raised their production capacities to meet the 25-30 per cent rise in demand expected in the coming months.

From Tesla to Mercedes, luxury carmakers head South

From Tesla to Mercedes, luxury carmakers head South

Rediff.com   11 Mar 2025

In 2024 alone, South India saw the highest rise in sales in the luxury segment, with Tamil Nadu reportedly registering a 19.3 per cent increase in premium car registrations from 2022-23

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com   27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

'It Was Always About The Bride'

'It Was Always About The Bride'

Rediff.com   25 Feb 2025

'Her story, her life, her aspirations and struggles...' 'Indian weddings are not just about fuschia, pink and dancing. They have many nuances.'

Why Tesla Entry is No Major Threat

Why Tesla Entry is No Major Threat

Rediff.com   24 Feb 2025

Tesla needs to either sell the same models with reduced features to lower the cost for Indian market, or incur losses.

'Couples Are Moving Beyond Dinner Dates'

'Couples Are Moving Beyond Dinner Dates'

Rediff.com   13 Feb 2025

With Valentine's Day falling on a Friday, travel is picking up as people look for quick getaways.

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com   11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com   10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

India To Develop 50 Tourism Sites

India To Develop 50 Tourism Sites

Rediff.com   3 Feb 2025

In a continued push to spiritual tourism, there will be a focus on destinations related to the life and times of Lord Buddha.

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com   3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

Trump's Tariff War: India Waits, Watches

Trump's Tariff War: India Waits, Watches

Rediff.com   3 Feb 2025

'We have to be prepared for the larger disruption that is likely to take place.'